These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

358 related articles for article (PubMed ID: 36074935)

  • 41. Leber congenital amaurosis: clinical correlations with genotypes, gene therapy trials update, and future directions.
    Chung DC; Traboulsi EI
    J AAPOS; 2009 Dec; 13(6):587-92. PubMed ID: 20006823
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Safety in nonhuman primates of ocular AAV2-RPE65, a candidate treatment for blindness in Leber congenital amaurosis.
    Jacobson SG; Boye SL; Aleman TS; Conlon TJ; Zeiss CJ; Roman AJ; Cideciyan AV; Schwartz SB; Komaromy AM; Doobrajh M; Cheung AY; Sumaroka A; Pearce-Kelling SE; Aguirre GD; Kaushal S; Maguire AM; Flotte TR; Hauswirth WW
    Hum Gene Ther; 2006 Aug; 17(8):845-58. PubMed ID: 16942444
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Genome Surgery and Gene Therapy in Retinal Disorders.
    Chan L; Mahajan VB; Tsang SH
    Yale J Biol Med; 2017 Dec; 90(4):523-532. PubMed ID: 29259518
    [TBL] [Abstract][Full Text] [Related]  

  • 44. An optometrist's guide to the top candidate inherited retinal diseases for gene therapy.
    O'Hare F; Edwards TL; Hu ML; Hickey DG; Zhang AC; Wang JH; Liu Z; Ayton LN
    Clin Exp Optom; 2021 May; 104(4):431-443. PubMed ID: 33689629
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Perspectives of people with inherited retinal diseases on ocular gene therapy in Australia: protocol for a national survey.
    Mack HG; Chen FK; Grigg J; Jamieson R; De Roach J; O'Hare F; Britten-Jones AC; McGuinness M; Tindill N; Ayton L;
    BMJ Open; 2021 Jun; 11(6):e048361. PubMed ID: 34158306
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Long-term expression of melanopsin and channelrhodopsin causes no gross alterations in the dystrophic dog retina.
    Ameline B; Tshilenge KT; Weber M; Biget M; Libeau L; Caplette R; Mendes-Madeira A; Provost N; Guihal C; Picaud S; Moullier P; Pichard V; Cronin T; Isiegas C
    Gene Ther; 2017 Nov; 24(11):735-741. PubMed ID: 28880021
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Antisense oligonucleotide therapeutics in clinical trials for the treatment of inherited retinal diseases.
    Xue K; MacLaren RE
    Expert Opin Investig Drugs; 2020 Oct; 29(10):1163-1170. PubMed ID: 32741234
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Molecular genetics of Leber congenital amaurosis.
    Cremers FP; van den Hurk JA; den Hollander AI
    Hum Mol Genet; 2002 May; 11(10):1169-76. PubMed ID: 12015276
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Evaluation of Ocular Gene Therapy in an Italian Patient Affected by Congenital Leber Amaurosis Type 2 Treated in Both Eyes.
    Testa F; Maguire AM; Rossi S; Marshall K; Auricchio A; Melillo P; Bennett J; Simonelli F
    Adv Exp Med Biol; 2016; 854():533-9. PubMed ID: 26427456
    [TBL] [Abstract][Full Text] [Related]  

  • 50. The Role of Gene Therapy in the Treatment of Retinal Diseases: A Review.
    Campa C; Gallenga CE; Bolletta E; Perri P
    Curr Gene Ther; 2017; 17(3):194-213. PubMed ID: 29149824
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Seeing is believing: gene therapy shows promise for ocular disorders.
    Friedrich MJ
    JAMA; 2010 Oct; 304(14):1543-5. PubMed ID: 20940376
    [No Abstract]   [Full Text] [Related]  

  • 52. Long-term restoration of rod and cone vision by single dose rAAV-mediated gene transfer to the retina in a canine model of childhood blindness.
    Acland GM; Aguirre GD; Bennett J; Aleman TS; Cideciyan AV; Bennicelli J; Dejneka NS; Pearce-Kelling SE; Maguire AM; Palczewski K; Hauswirth WW; Jacobson SG
    Mol Ther; 2005 Dec; 12(6):1072-82. PubMed ID: 16226919
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Hopeful vision. Gene therapy restores human sight.
    Jabr F
    Sci Am; 2012 Apr; 306(4):15. PubMed ID: 22486105
    [No Abstract]   [Full Text] [Related]  

  • 54. Retained Plasticity and Substantial Recovery of Rod-Mediated Visual Acuity at the Visual Cortex in Blind Adult Mice with Retinal Dystrophy.
    Nishiguchi KM; Fujita K; Tokashiki N; Komamura H; Takemoto-Kimura S; Okuno H; Bito H; Nakazawa T
    Mol Ther; 2018 Oct; 26(10):2397-2406. PubMed ID: 30064895
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Full-field stimulus testing: Role in the clinic and as an outcome measure in clinical trials of severe childhood retinal disease.
    Roman AJ; Cideciyan AV; Wu V; Garafalo AV; Jacobson SG
    Prog Retin Eye Res; 2022 Mar; 87():101000. PubMed ID: 34464742
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Preserved outer retina in AIPL1 Leber's congenital amaurosis: implications for gene therapy.
    Aboshiha J; Dubis AM; van der Spuy J; Nishiguchi KM; Cheeseman EW; Ayuso C; Ehrenberg M; Simonelli F; Bainbridge JW; Michaelides M
    Ophthalmology; 2015 Apr; 122(4):862-4. PubMed ID: 25596619
    [No Abstract]   [Full Text] [Related]  

  • 57. The effect of human gene therapy for RPE65-associated Leber's congenital amaurosis on visual function: a systematic review and meta-analysis.
    Wang X; Yu C; Tzekov RT; Zhu Y; Li W
    Orphanet J Rare Dis; 2020 Feb; 15(1):49. PubMed ID: 32059734
    [TBL] [Abstract][Full Text] [Related]  

  • 58. RPE65: role in the visual cycle, human retinal disease, and gene therapy.
    Cai X; Conley SM; Naash MI
    Ophthalmic Genet; 2009 Jun; 30(2):57-62. PubMed ID: 19373675
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Screening of SPATA7 in patients with Leber congenital amaurosis and severe childhood-onset retinal dystrophy reveals disease-causing mutations.
    Mackay DS; Ocaka LA; Borman AD; Sergouniotis PI; Henderson RH; Moradi P; Robson AG; Thompson DA; Webster AR; Moore AT
    Invest Ophthalmol Vis Sci; 2011 May; 52(6):3032-8. PubMed ID: 21310915
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Non-syndromic retinal ciliopathies: translating gene discovery into therapy.
    Estrada-Cuzcano A; Roepman R; Cremers FP; den Hollander AI; Mans DA
    Hum Mol Genet; 2012 Oct; 21(R1):R111-24. PubMed ID: 22843501
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.